Literature DB >> 12928769

Technical aspects of islet preparation and transplantation.

Jonathan R T Lakey1, Philip W Burridge, A M James Shapiro.   

Abstract

The introduction of insulin therapy for the management of diabetes mellitus is arguably the greatest milestone in the history of modern medicine. beta-cell replacement therapy is the only treatment that reestablishes and maintains long-term physiological normoglycemia. Until recently, successful clinical outcomes of pancreas transplantation for patients with long-standing diabetes were much superior to that of islet transplantation. Significant advances in islet isolation and purification technology, the development of more specific and less diabetogenic immunosuppressants and the prophylactic administration of antiviral agents have rekindled a worldwide interest in islet transplantation. This chapter will review the rationale of islet transplantation and the development of islet isolation and purification. The challenges facing clinical islet transplantation in the twenty-first century will also be introduced.

Entities:  

Mesh:

Year:  2003        PMID: 12928769     DOI: 10.1007/s00147-003-0651-x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  21 in total

Review 1.  Radiologic aspects of islet cell transplantation.

Authors:  Ziv Neeman; Boaz Hirshberg; David Harlan; Bradford J Wood
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

2.  Quantification of basal and stimulated ROS levels as predictors of islet potency and function.

Authors:  B Armann; M S Hanson; E Hatch; A Steffen; L A Fernandez
Journal:  Am J Transplant       Date:  2007-01       Impact factor: 8.086

3.  A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products.

Authors:  A N Balamurugan; Gopalakrishnan Loganathan; Melena D Bellin; Joshua J Wilhelm; James Harmon; Takayuki Anazawa; Sajjad M Soltani; David M Radosevich; Takeshi Yuasa; Mukesh Tiwari; Klearchos K Papas; Robert McCarthy; David E R Sutherland; Bernhard J Hering
Journal:  Transplantation       Date:  2012-04-15       Impact factor: 4.939

4.  Different digestion enzymes used for human pancreatic islet isolation: a mixed treatment comparison (MTC) meta-analysis.

Authors:  Jakeline Rheinheimer; Patrícia Klarmann Ziegelmann; Rodrigo Carlessi; Luciana Ross Reck; Andrea Carla Bauer; Cristiane Bauermann Leitão; Daisy Crispim
Journal:  Islets       Date:  2014-11-07       Impact factor: 2.694

5.  Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice.

Authors:  Xianyang Zhang; Tengjiao Cui; Jinlin He; Haibo Wang; Renzhi Cai; Petra Popovics; Irving Vidaurre; Wei Sha; Janine Schmid; Barbara Ludwig; Norman L Block; Stefan R Bornstein; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-16       Impact factor: 11.205

6.  Filtration is a time-efficient option to Histopaque, providing good-quality islets in mouse islet isolation.

Authors:  Miriam Ramírez-Domínguez; Luis Castaño
Journal:  Cytotechnology       Date:  2014-01-19       Impact factor: 2.058

7.  A stirred microchamber for oxygen consumption rate measurements with pancreatic islets.

Authors:  Klearchos K Papas; Anna Pisania; Haiyan Wu; Gordon C Weir; Clark K Colton
Journal:  Biotechnol Bioeng       Date:  2007-12-01       Impact factor: 4.530

8.  Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone.

Authors:  Undine Schubert; Janine Schmid; Susann Lehmann; Xian Y Zhang; Henning Morawietz; Norman L Block; Waldemar Kanczkowski; Andrew V Schally; Stefan R Bornstein; Barbara Ludwig
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

9.  Pancreatic Transplantation: Beta Cell Replacement.

Authors:  David L. Bigam; AM James Shapiro
Journal:  Curr Treat Options Gastroenterol       Date:  2004-10

10.  Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation.

Authors:  A Fornoni; A Pileggi; R D Molano; N Y Sanabria; T Tejada; J Gonzalez-Quintana; H Ichii; L Inverardi; C Ricordi; R L Pastori
Journal:  Diabetologia       Date:  2007-12-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.